Innate and cell-mediated immune responses to Cryptosporidium parvum
- PMID: 9554071
- DOI: 10.1016/s0065-308x(08)60118-9
Innate and cell-mediated immune responses to Cryptosporidium parvum
Abstract
Cryptosporidium parvum has gained much attention as a major cause of diarrhea in the world. Knowledge of the host immune mechanisms responsible for the clearance of this parasite from the gastrointestinal tract may prove to be vital for successful therapeutic treatment of cryptosporidiosis, particularly in the immunodeficient host. This chapter focuses on the innate and cell-mediated immune mechanisms associated with resistance to and resolution of a C. parvum infection. Much of the work in these areas is still in its infancy. Despite this, general consensus supports a role for interferon-gamma (IFN gamma) in mediating the initial resistance to C. parvum, although the mechanism by which this cytokine imparts resistance is unclear. It is also generally agreed that CD4+ T lymphocytes are required for the resolution of both acute and chronic cryptosporidiosis. However, the effector mechanism is again unclear. Several studies suggest that IFN gamma may also be involved in the resolution of cryptosporidiosis. However, the extent to which this cytokine is involved in the actual resolution of infection has been debated. Less extensive studies investigating the participation of other cells and cytokines in the innate and cell-mediated immune responses to C. parvum are also discussed.
Similar articles
-
Recent advances in cryptosporidiosis: the immune response.Microbes Infect. 2002 Aug;4(10):1067-80. doi: 10.1016/s1286-4579(02)01631-3. Microbes Infect. 2002. PMID: 12191657 Review.
-
Dynamics of gut mucosal and systemic Th1/Th2 cytokine responses in interferon-gamma and interleukin-12p40 knock out mice during primary and challenge Cryptosporidium parvum infection.Immunobiology. 2009;214(6):454-66. doi: 10.1016/j.imbio.2008.11.015. Epub 2009 Jan 19. Immunobiology. 2009. PMID: 19155092
-
Innate immune responses against Cryptosporidium parvum infection.Parasite Immunol. 2013 Feb;35(2):55-64. doi: 10.1111/pim.12020. Parasite Immunol. 2013. PMID: 23173616 Review.
-
MyD88-dependent pathways mediate resistance to Cryptosporidium parvum infection in mice.Infect Immun. 2006 Jan;74(1):549-56. doi: 10.1128/IAI.74.1.549-556.2006. Infect Immun. 2006. PMID: 16369011 Free PMC article.
-
Molecular targets for detection and immunotherapy in Cryptosporidium parvum.Biotechnol Adv. 2007 Jan-Feb;25(1):13-44. doi: 10.1016/j.biotechadv.2006.08.003. Epub 2006 Aug 30. Biotechnol Adv. 2007. PMID: 17055210 Review.
Cited by
-
Pathogenicity of Cryptosporidium parvum--evaluation of an animal infection model.Vet Parasitol. 2003 Apr 2;113(1):35-57. doi: 10.1016/s0304-4017(03)00034-7. Vet Parasitol. 2003. PMID: 12651216 Free PMC article.
-
An early intestinal mucosal source of gamma interferon is associated with resistance to and control of Cryptosporidium parvum infection in mice.Infect Immun. 2005 Dec;73(12):8425-8. doi: 10.1128/IAI.73.12.8425-8428.2005. Infect Immun. 2005. PMID: 16299343 Free PMC article.
-
Absence of CD40-CD40 ligand interactions in X-linked hyper-IgM syndrome does not affect differentiation of T helper cell subsets.Clin Exp Immunol. 2000 Aug;121(2):346-52. doi: 10.1046/j.1365-2249.2000.01307.x. Clin Exp Immunol. 2000. PMID: 10931152 Free PMC article.
-
Cryptosporidiosis in paediatric renal transplantation.Pediatr Nephrol. 2009 Nov;24(11):2245-55. doi: 10.1007/s00467-009-1274-y. Pediatr Nephrol. 2009. PMID: 19714369
-
Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients.Clin Microbiol Rev. 2002 Jan;15(1):145-54. doi: 10.1128/CMR.15.1.145-154.2002. Clin Microbiol Rev. 2002. PMID: 11781272 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials